Skip to main content
. 2023 Mar 8;11(3):617. doi: 10.3390/vaccines11030617

Table 1.

Principal advanced glycation end products (AGEs) investigated in patients with psoriasis.

AGEs Other RAGE Ligands
Carboxymethylysine (CML) Psoriasin (S100A7)
Carboxyethyllysine (CEL) Koebnerisin (S100A15)
Pyrraline High-mobility group protein B1 (HMGB1)
Pentosidine
Glyoxal-lysine dimer (GOLD)
Deoxyglucasone-lysine dimer (DOLD)
Methyl glyoxal-lysine dimer (MOLD)
N-lactatolysine